Privacy preference
MEDtalks would like to keep you informed about the content that is most relevant to you. Click
here
for more information.
Yes
No
Back
Trastuzumab deruxtecan (T-DXd) bij patiƫnten met HER2 gemetastaseerd mammacarcinoom en hersenmetastasen
Chat with us
, powered by
LiveChat